Clinical Trial Update: Identification of CETP as a Marker of Atherosclerosis [NA]

View source ↗

Summary

Clinical trial update identifying CETP as a biomarker of atherosclerosis. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Cardiovascular Disease | NA | Status: COMPLETED